請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/46203完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 蔡錦華(Ching-Hwa Tsai) | |
| dc.contributor.author | Tzu-Hsun Tung | en |
| dc.contributor.author | 董姿巡 | zh_TW |
| dc.date.accessioned | 2021-06-15T04:57:54Z | - |
| dc.date.available | 2020-12-31 | |
| dc.date.copyright | 2010-09-09 | |
| dc.date.issued | 2010 | |
| dc.date.submitted | 2010-07-29 | |
| dc.identifier.citation | Amon, W., and Farrell, P.J. (2005). Reactivation of Epstein-Barr virus from latency. Rev Med Virol 15, 149-156.
Baer, R., Bankier, A.T., Biggin, M.D., Deininger, P.L., Farrell, P.J., Gibson, T.J., Hatfull, G., Hudson, G.S., Satchwell, S.C., Seguin, C., et al. (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207-211. Baik, S.Y., Yun, H.S., Lee, H.J., Lee, M.H., Jung, S.E., Kim, J.W., Jeon, J.P., Shin, Y.K., Rhee, H.S., Kimm, K.C., et al. (2007). Identification of stathmin 1 expression induced by Epstein-Barr virus in human B lymphocytes. Cell Prolif 40, 268-281. Bang, Y.J., Kwon, J.H., Kang, S.H., Kim, J.W., and Yang, Y.C. (1998). Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. Biochem Biophys Res Commun 250, 43-47. Bogoyevitch, M.A., and Court, N.W. (2004). Counting on mitogen-activated protein kinases--ERKs 3, 4, 5, 6, 7 and 8. Cell Signal 16, 1345-1354. Bonnet, M., Guinebretiere, J.M., Kremmer, E., Grunewald, V., Benhamou, E., Contesso, G., and Joab, I. (1999). Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 91, 1376-1381. Brondello, J.M., Brunet, A., Pouyssegur, J., and McKenzie, F.R. (1997). The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J Biol Chem 272, 1368-1376. Brondello, J.M., Pouyssegur, J., and McKenzie, F.R. (1999). Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286, 2514-2517. Brunet, A., Roux, D., Lenormand, P., Dowd, S., Keyse, S., and Pouyssegur, J. (1999). Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J 18, 664-674. Burkhardt, A.L., Bolen, J.B., Kieff, E., and Longnecker, R. (1992). An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J Virol 66, 5161-5167. Camps, M., Chabert, C., Muda, M., Boschert, U., Gillieron, C., and Arkinstall, S. (1998a). Induction of the mitogen-activated protein kinase phosphatase MKP3 by nerve growth factor in differentiating PC12. FEBS Lett 425, 271-276. Camps, M., Nichols, A., and Arkinstall, S. (2000). Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 14, 6-16. Camps, M., Nichols, A., Gillieron, C., Antonsson, B., Muda, M., Chabert, C., Boschert, U., and Arkinstall, S. (1998b). Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280, 1262-1265. Chan, D.W., Liu, V.W., Tsao, G.S., Yao, K.M., Furukawa, T., Chan, K.K., and Ngan, H.Y. (2008). Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis 29, 1742-1750. Chang, Y., Lee, H.H., Chang, S.S., Hsu, T.Y., Wang, P.W., Chang, Y.S., Takada, K., and Tsai, C.H. (2004). Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta. J Virol 78, 13028-13036. Chang, Y., Tung, C.H., Huang, Y.T., Lu, J., Chen, J.Y., and Tsai, C.H. (1999). Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J Virol 73, 8857-8866. Chen, P., Li, J., Barnes, J., Kokkonen, G.C., Lee, J.C., and Liu, Y. (2002). Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol 169, 6408-6416. Chen, X., Liang, S., Zheng, W., Liao, Z., Shang, T., and Ma, W. (2008). Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation. BMC Genomics 9, 322. Chevallier-Greco, A., Manet, E., Chavrier, P., Mosnier, C., Daillie, J., and Sergeant, A. (1986). Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J 5, 3243-3249. Cho, M.S., Milman, G., and Hayward, S.D. (1985). A second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein. J Virol 56, 860-866. Clough, W. (1979). Deoxyribonuclease activity found in Epstein--Barr virus producing lymphoblastoid cells. Biochemistry 18, 4517-4521. Countryman, J., and Miller, G. (1985). Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci U S A 82, 4085-4089. Dambaugh, T., Beisel, C., Hummel, M., King, W., Fennewald, S., Cheung, A., Heller, M., Raab-Traub, N., and Kieff, E. (1980). Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping. Proc Natl Acad Sci U S A 77, 2999-3003. Denu, J.M., and Dixon, J.E. (1998). Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Curr Opin Chem Biol 2, 633-641. Dhar, V., and Schildkraut, C.L. (1991). Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats. Mol Cell Biol 11, 6268-6278. Dickinson, R.J., and Keyse, S.M. (2006). Diverse physiological functions for dual-specificity MAP kinase phosphatases. J Cell Sci 119, 4607-4615. Dolyniuk, M., Pritchett, R., and Kieff, E. (1976a). Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. J Virol 17, 935-949. Dolyniuk, M., Wolff, E., and Kieff, E. (1976b). Proteins of Epstein-Barr Virus. II. Electrophoretic analysis of the polypeptides of the nucleocapsid and the glucosamine- and polysaccharide-containing components of enveloped virus. J Virol 18, 289-297. Dowd, S., Sneddon, A.A., and Keyse, S.M. (1998). Isolation of the human genes encoding the pyst1 and Pyst2 phosphatases: characterisation of Pyst2 as a cytosolic dual-specificity MAP kinase phosphatase and its catalytic activation by both MAP and SAP kinases. J Cell Sci 111 ( Pt 22), 3389-3399. Epstein, M.A., Achong, B.G., and Barr, Y.M. (1964). Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma. Lancet 1, 702-703. Fingeroth, J.D., Weis, J.J., Tedder, T.F., Strominger, J.L., Biro, P.A., and Fearon, D.T. (1984). Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A 81, 4510-4514. Furukawa, T., Sunamura, M., Motoi, F., Matsuno, S., and Horii, A. (2003). Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am J Pathol 162, 1807-1815. Gires, O., Zimber-Strobl, U., Gonnella, R., Ueffing, M., Marschall, G., Zeidler, R., Pich, D., and Hammerschmidt, W. (1997). Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 16, 6131-6140. Greenspan, J.S., Greenspan, D., Lennette, E.T., Abrams, D.I., Conant, M.A., Petersen, V., and Freese, U.K. (1985). Replication of Epstein-Barr virus within the epithelial cells of oral 'hairy' leukoplakia, an AIDS-associated lesion. N Engl J Med 313, 1564-1571. Groom, L.A., Sneddon, A.A., Alessi, D.R., Dowd, S., and Keyse, S.M. (1996). Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J 15, 3621-3632. Grumont, R.J., Rasko, J.E., Strasser, A., and Gerondakis, S. (1996). Activation of the mitogen-activated protein kinase pathway induces transcription of the PAC-1 phosphatase gene. Mol Cell Biol 16, 2913-2921. Guan, K.L., Broyles, S.S., and Dixon, J.E. (1991). A Tyr/Ser protein phosphatase encoded by vaccinia virus. Nature 350, 359-362. Han, J., and Sun, P. (2007). The pathways to tumor suppression via route p38. Trends Biochem Sci 32, 364-371. Hardwick, J.M., Lieberman, P.M., and Hayward, S.D. (1988). A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J Virol 62, 2274-2284. Hatfull, G., Bankier, A.T., Barrell, B.G., and Farrell, P.J. (1988). Sequence analysis of Raji Epstein-Barr virus DNA. Virology 164, 334-340. Hazzalin, C.A., and Mahadevan, L.C. (2002). MAPK-regulated transcription: a continuously variable gene switch? Nat Rev Mol Cell Biol 3, 30-40. Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G., and Rickinson, A. (1993). Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A 90, 8479-8483. Henle, G., and Henle, W. (1966). Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol 91, 1248-1256. Henle, G., Henle, W., and Diehl, V. (1968). Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A 59, 94-101. Hoshino, R., Chatani, Y., Yamori, T., Tsuruo, T., Oka, H., Yoshida, O., Shimada, Y., Ari-i, S., Wada, H., Fujimoto, J., et al. (1999). Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene 18, 813-822. Hsu, T.Y., Chang, Y., Wang, P.W., Liu, M.Y., Chen, M.R., Chen, J.Y., and Tsai, C.H. (2005). Reactivation of Epstein-Barr virus can be triggered by an Rta protein mutated at the nuclear localization signal. J Gen Virol 86, 317-322. Hurley, E.A., Agger, S., McNeil, J.A., Lawrence, J.B., Calendar, A., Lenoir, G., and Thorley-Lawson, D.A. (1991). When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates. J Virol 65, 1245-1254. Imai, S., Nishikawa, J., and Takada, K. (1998). Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72, 4371-4378. J. Sambrook, E.F.F., T. Maniatis (1989). Mocular Cloning, Second Edition edn (New York, Cold Spring Harbor Laboratory Press). Jeffrey, K.L., Brummer, T., Rolph, M.S., Liu, S.M., Callejas, N.A., Grumont, R.J., Gillieron, C., Mackay, F., Grey, S., Camps, M., et al. (2006). Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1. Nat Immunol 7, 274-283. Kaye, K.M., Izumi, K.M., Mosialos, G., and Kieff, E. (1995). The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues. J Virol 69, 675-683. Keyse, S.M. (2000). Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 12, 186-192. Keyse, S.M., and Emslie, E.A. (1992). Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 359, 644-647. Kikuta, H., Taguchi, Y., Tomizawa, K., Kojima, K., Kawamura, N., Ishizaka, A., Sakiyama, Y., Matsumoto, S., Imai, S., Kinoshita, T., et al. (1988). Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333, 455-457. Klein, G., Clifford, P., Klein, E., and Stjernsward, J. (1966). Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci U S A 55, 1628-1635. Laderoute, K.R., Mendonca, H.L., Calaoagan, J.M., Knapp, A.M., Giaccia, A.J., and Stork, P.J. (1999). Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity. J Biol Chem 274, 12890-12897. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P.M., Klein, G., Kurilla, M.G., and Masucci, M.G. (1995). Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375, 685-688. Liao, Q., Guo, J., Kleeff, J., Zimmermann, A., Buchler, M.W., Korc, M., and Friess, H. (2003). Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells. Gastroenterology 124, 1830-1845. Lin, Y.W., and Yang, J.L. (2006). Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling. J Biol Chem 281, 915-926. Littler, E., Zeuthen, J., McBride, A.A., Trost Sorensen, E., Powell, K.L., Walsh-Arrand, J.E., and Arrand, J.R. (1986). Identification of an Epstein-Barr virus-coded thymidine kinase. EMBO J 5, 1959-1966. Liu, Y., Shepherd, E.G., and Nelin, L.D. (2007). MAPK phosphatases--regulating the immune response. Nat Rev Immunol 7, 202-212. Liu, Y.X., Wang, J., Guo, J., Wu, J., Lieberman, H.B., and Yin, Y. (2008). DUSP1 is controlled by p53 during the cellular response to oxidative stress. Mol Cancer Res 6, 624-633. Loda, M., Capodieci, P., Mishra, R., Yao, H., Corless, C., Grigioni, W., Wang, Y., Magi-Galluzzi, C., and Stork, P.J. (1996). Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am J Pathol 149, 1553-1564. Luka, J., Kallin, B., and Klein, G. (1979). Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94, 228-231. Menezes, J., Leibold, W., Klein, G., and Clements, G. (1975). Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine 22, 276-284. Meng, T.C., Fukada, T., and Tonks, N.K. (2002). Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9, 387-399. Miller, R.L., Glaser, R., and Rapp, F. (1977). Studies of an Epstein-Barr virus-induced DNA polymerase. Virology 76, 494-502. Miyashita, E.M., Yang, B., Babcock, G.J., and Thorley-Lawson, D.A. (1997). Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 71, 4882-4891. Morrison, D.J., Kim, M.K., Berkofsky-Fessler, W., and Licht, J.D. (2008). WT1 induction of mitogen-activated protein kinase phosphatase 3 represents a novel mechanism of growth suppression. Mol Cancer Res 6, 1225-1231. Muda, M., Theodosiou, A., Rodrigues, N., Boschert, U., Camps, M., Gillieron, C., Davies, K., Ashworth, A., and Arkinstall, S. (1996). The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J Biol Chem 271, 27205-27208. Nemerow, G.R., Mold, C., Schwend, V.K., Tollefson, V., and Cooper, N.R. (1987). Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol 61, 1416-1420. Nonoyama, M., Huang, C.H., Pagano, J.S., Klein, G., and Singh, S. (1973). DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci U S A 70, 3265-3268. Okudela, K., Yazawa, T., Woo, T., Sakaeda, M., Ishii, J., Mitsui, H., Shimoyamada, H., Sato, H., Tajiri, M., Ogawa, N., et al. (2009). Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis. Am J Pathol 175, 867-881. Patterson, K.I., Brummer, T., O'Brien, P.M., and Daly, R.J. (2009). Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J 418, 475-489. Rauhala, H.E., Porkka, K.P., Tolonen, T.T., Martikainen, P.M., Tammela, T.L., and Visakorpi, T. (2005). Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer. Int J Cancer 117, 738-745. Salmeen, A., Andersen, J.N., Myers, M.P., Meng, T.C., Hinks, J.A., Tonks, N.K., and Barford, D. (2003). Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423, 769-773. Satoh, T., Fukuda, M., and Sairenji, T. (2002). Distinct patterns of mitogen-activated protein kinase phosphorylation and Epstein-Barr virus gene expression in Burkitt's lymphoma cell lines versus B lymphoblastoid cell lines. Virus Genes 25, 15-21. Sekine, Y., Tsuji, S., Ikeda, O., Sato, N., Aoki, N., Aoyama, K., Sugiyama, K., and Matsuda, T. (2006). Regulation of STAT3-mediated signaling by LMW-DSP2. Oncogene 25, 5801-5806. Seta, K.A., Kim, R., Kim, H.W., Millhorn, D.E., and Beitner-Johnson, D. (2001). Hypoxia-induced regulation of MAPK phosphatase-1 as identified by subtractive suppression hybridization and cDNA microarray analysis. J Biol Chem 276, 44405-44412. Shibata, D., and Weiss, L.M. (1992). Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140, 769-774. Shimizu, N., Tanabe-Tochikura, A., Kuroiwa, Y., and Takada, K. (1994). Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 68, 6069-6073. Shimizu, N., Yoshiyama, H., and Takada, K. (1996). Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol 70, 7260-7263. Sixbey, J.W., Vesterinen, E.H., Nedrud, J.G., Raab-Traub, N., Walton, L.A., and Pagano, J.S. (1983). Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 306, 480-483. Small, G.W., Shi, Y.Y., Edmund, N.A., Somasundaram, S., Moore, D.T., and Orlowski, R.Z. (2004). Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role. Mol Pharmacol 66, 1478-1490. Su, I.J., and Hsieh, H.C. (1992). Clinicopathological spectrum of Epstein-Barr virus-associated T cell malignancies. Leuk Lymphoma 7, 47-53. Sun, H., Charles, C.H., Lau, L.F., and Tonks, N.K. (1993). MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75, 487-493. Takada, K. (1984). Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 33, 27-32. Takada, K., and Ono, Y. (1989). Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol 63, 445-449. Thorley-Lawson, D.A., and Gross, A. (2004). Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350, 1328-1337. Tsai, C.H., Liu, M.T., Chen, M.R., Lu, J., Yang, H.L., Chen, J.Y., and Yang, C.S. (1997). Characterization of Monoclonal Antibodies to the Zta and DNase Proteins of Epstein-Barr Virus. J Biomed Sci 4, 69-77. Tsai, W.S., Chang, M.H., Chen, J.Y., Lee, C.Y., and Liu, Y.G. (1989). Seroepidemiological study of Epstein-Barr virus infection in children in Taipei. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 30, 81-86. Tsao, S.W., Tramoutanis, G., Dawson, C.W., Lo, A.K., and Huang, D.P. (2002). The significance of LMP1 expression in nasopharyngeal carcinoma. Semin Cancer Biol 12, 473-487. Uchida, J., Yasui, T., Takaoka-Shichijo, Y., Muraoka, M., Kulwichit, W., Raab-Traub, N., and Kikutani, H. (1999). Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286, 300-303. Vicent, S., Garayoa, M., Lopez-Picazo, J.M., Lozano, M.D., Toledo, G., Thunnissen, F.B., Manzano, R.G., and Montuenga, L.M. (2004). Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Clin Cancer Res 10, 3639-3649. Weiss, L.M., Movahed, L.A., Warnke, R.A., and Sklar, J. (1989). Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320, 502-506. Xu, S., Furukawa, T., Kanai, N., Sunamura, M., and Horii, A. (2005). Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. J Hum Genet 50, 159-167. Yates, J.L., Warren, N., and Sugden, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-815. Yolanda Bayón, A.A. (2010). Atypical DUSPs: 19 phosphatases in search of a role Emerging Signaling Pathways in Tumor Biology, 185-208. Young, L.S., and Rickinson, A.B. (2004). Epstein-Barr virus: 40 years on. Nat Rev Cancer 4, 757-768. Yuan, J., Cahir-McFarland, E., Zhao, B., and Kieff, E. (2006). Virus and cell RNAs expressed during Epstein-Barr virus replication. J Virol 80, 2548-2565. Zama, T., Aoki, R., Kamimoto, T., Inoue, K., Ikeda, Y., and Hagiwara, M. (2002). A novel dual specificity phosphatase SKRP1 interacts with the MAPK kinase MKK7 and inactivates the JNK MAPK pathway. Implication for the precise regulation of the particular MAPK pathway. J Biol Chem 277, 23909-23918. Zufferey, R., Dull, T., Mandel, R.J., Bukovsky, A., Quiroz, D., Naldini, L., and Trono, D. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72, 9873-9880. zur Hausen, H., Bornkamm, G.W., Schmidt, R., and Hecker, E. (1979). Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc Natl Acad Sci U S A 76, 782-785. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/46203 | - |
| dc.description.abstract | EB病毒(Epstein-Barr virus，EBV)為人類第四型皰疹病毒，是一種帶有外套膜的雙股DNA病毒，主要感染人類B淋巴球細胞，此外也會感染上皮細胞和T淋巴球細胞。EB病毒具有將B淋巴球細胞轉形成為不朽的淋巴母細胞株之能力，在EB病毒感染初級B淋巴球細胞並將之轉形的過程中，會誘發許多訊息傳遞路徑的活化，像是NF-κB，PI3K及MAPK訊息傳遞路徑等等。
先前實驗室經由cDNA微陣列分析EB病毒感染CD19+初級B淋巴球細胞後細胞中基因的表現變化，發現一群隸屬於DUSPs(dual-specificity phosphatases)家族的去磷酸酶的表現量會有所差異。DUSPs隸屬於酪胺酸去磷酸酶(PTP)家族的一員，可以同時針對同一個受質上的磷酸化色胺酸或磷酸化酥胺酸(phospho-Ser/ phospho-Thr)和磷酸化酪胺酸(phosphor-Tyr)上進行去磷酸化作用。DUSP家族中有許多成員被報導對於MAPK訊息傳遞路徑具有特異性負向調控的功能。 在此研究中，我們進一步利用即時定量聚合酶連鎖反應(real-time PCR)與反轉錄聚合酶連鎖反應(RT-PCR)檢驗，證實利用B95.8 EB病毒株感染自白血球濃厚液中純化出來的CD19+ B細胞後，被EB病毒感染之細胞內的某些DUSPs表現量的確有顯著變的趨勢。本研究發現許多DUSPs像是DUSP1、DUSP5、DUSP6、DUSP7、DUSP8、DUSP16、DUSP19和DUSP22，它們在細胞中的表現量會隨著病毒感染和轉形的過程而有降低的趨勢，這暗示著EB病毒除了透過自身的病毒基因如LMP1和LMP2A正向調控MAPK訊息傳遞路徑之外，或許也透過了另一條負向調控的路徑來協助MAPK訊號得以在轉形的過程中持續活化。 此外，我們也發現在淋巴母細胞株中轉染DUSP1或DUSP6基因會影響淋巴母細胞株中的生長與凋亡，這或許反映了為何在轉形過程中這些DUSPs基因的表現需要受到調控。然而，關於EB病毒究竟如何調控細胞中DUSPs表現的機制則尚待更進一步地探討。 | zh_TW |
| dc.description.abstract | Epstein-Barr virus (EBV) is a oncogenic gamma-herpesvirus that persistently infects over 90% of the human population. EBV-encoded genes have been shown to be involved in immune evasion and in the regulation of various cellular signaling cascades, including MAPK, PI3K/AKT and NF-κB pathway.
Dual-specificity phosphatases (DUSPs) are a subset of protein tyrosine phosphatases, that can dephosphorylate both phosphotyrosine and phosphoserine/ phosphothreonine residues within the one substrate. DUSP family is proposed as a set of molecular control devices specifying and modulating MAPK signaling, the regulated expression and activity of DUSP family members in different cells and tissues controls MAPK intensity and duration to determine the type of physiological response. Previous research indicates that many cellular gene expressions are altered after EBV infection. By cDNA microarray analysis, we found that several DUSPs expression would be changed during EBV infection in human CD19+ B cells, such as DUSP1、DUSP5、DUSP6、DUSP7、DUSP8、DUSP16、DUSP19 and DUSP22. Further study by Q-PCR and RT-PCR shows that DUDP1 and DUSP6 would significantly down-regulated in EBV-transformed lymphoblastoid cell lines (LCLs). Further study shows that, ectopic expression of DUDP1 and DUSP6 would result in down-regulation of cell proliferation, but not alteration of cell cycle distribution. However, the detail correlation between EBV and DUSPs need further research to investigate. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T04:57:54Z (GMT). No. of bitstreams: 1 ntu-99-R97445118-1.pdf: 6238670 bytes, checksum: 2421e14eab8cafc0c1400983ce9e9b17 (MD5) Previous issue date: 2010 | en |
| dc.description.tableofcontents | 口試委員會審定書……………………………… I
誌謝………………………………………………II 中文摘要…………………………………………III 英文摘要…………………………………………IV 序論………………………………………………1 實驗目的…………………………………………18 實驗材料與方法…………………………………19 實驗結果…………………………………………38 討論………………………………………………43 表…………………………………………………50 圖…………………………………………………58 附錄………………………………………………82 參考文獻…………………………………………87 | |
| dc.language.iso | zh-TW | |
| dc.subject | 淋巴母細胞株 | zh_TW |
| dc.subject | 雙重特異性去磷酸酶 | zh_TW |
| dc.subject | 絲裂原活化蛋白激酶 | zh_TW |
| dc.subject | EB病毒 | zh_TW |
| dc.subject | LCL | en |
| dc.subject | EBV | en |
| dc.subject | MAPK | en |
| dc.subject | DUSP | en |
| dc.title | 探討雙重特異性去磷酸酶在EB病毒感染細胞中之角色 | zh_TW |
| dc.title | Investigating the Role of Dual-Specificity Phosphatases in Epstein-Barr Virus Infected Cells | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 98-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 許翠瑛(Tsuey-Ying Hsu),林素珍(Sue-Jane Lin) | |
| dc.subject.keyword | 雙重特異性去磷酸酶,絲裂原活化蛋白激酶,EB病毒,淋巴母細胞株, | zh_TW |
| dc.subject.keyword | DUSP,MAPK,EBV,LCL, | en |
| dc.relation.page | 96 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2010-07-29 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 微生物學研究所 | zh_TW |
| 顯示於系所單位： | 微生物學科所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-99-1.pdf 未授權公開取用 | 6.09 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。